Development of a Novel Marine-Derived Tricomposite Biomaterial for Bone Regeneration

• Published in: Marine drugs Vol. 21; no. 9; p. 473
• Main Authors: Aslam, Bilal, Augustyniak, Aleksandra, Clarke, Susan A, McMahon, Helena
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 28.08.2023; MDPI
• Subjects: Alkaline phosphatase; Autografts; Biocompatibility; Biomaterials; Biomedical materials; Biomimetics; Bone biomaterials; Bone growth; Bone loss; Bone regeneration; bone tissue engineering; Bones; Calcium; Cell adhesion; Cell differentiation; Cell growth; Cell migration; Cell proliferation; Chitosan; Composite materials; Cytotoxicity; Defects; Differentiation; Environmental aspects; Fucoidan; Growth factors; Hydroxyapatite; Mesenchymal stem cells; Methods; Mineralization; Nanoparticles; Osteogenesis; Phosphatase; Porosity; Product development; Proliferation; Regeneration; Regeneration (biological); Regeneration (physiology); Scaffolds; Scanning electron microscopy; Skin & tissue grafts; Spectrum analysis; Stem cells; Tissue; Tissue engineering; Ireland
• ISSN: 1660-3397; 1660-3397
• DOI: 10.3390/md21090473

Bone tissue engineering is a promising treatment for bone loss that requires a combination of porous scaffold and osteogenic cells. The aim of this study was to evaluate and develop a tricomposite, biomimetic scaffold consisting of marine-derived biomaterials, namely, chitosan and fucoidan with hydroxyapatite (HA). The effects of chitosan, fucoidan and HA individually and in combination on the proliferation and differentiation of human mesenchymal stem cells (MSCs) were investigated. According to the SEM results, the tricomposite scaffold had a uniform porous structure, which is a key requirement for cell migration, proliferation and vascularisation. The presence of HA and fucoidan in the chitosan tricomposite scaffold was confirmed using FTIR, which showed a slight decrease in porosity and an increase in the density of the tricomposite scaffold compared to other formulations. Fucoidan was found to inhibit cell proliferation at higher concentrations and at earlier time points when applied as a single treatment, but this effect was lost at later time points. Similar results were observed with HA alone. However, both HA and fucoidan increased MSC mineralisation as measured by calcium deposition. Differentiation was significantly enhanced in MSCs cultured on the tricomposite, with increased alkaline phosphatase activity on days 17 and 25. In conclusion, the tricomposite is biocompatible, promotes osteogenesis, and has the structural and compositional properties required of a scaffold for bone tissue engineering. This biomaterial could provide an effective treatment for small bone defects as an alternative to autografts or be the basis for cell attachment and differentiation in ex vivo bone tissue engineering.